The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status

ObjectiveA goal of asthma management is to improve the patient’s health-related quality of life (HRQL). However, it is unclear whether HRQL instruments can discriminate across asthma control measures. The objective of this study was to evaluate the validity of generic and condition-specific preference-based instruments, in terms of their ability to distinguish asthma control.MethodsAsthma patients (n = 157) completed three generic preference-based instruments: the Health Utility Index Mark 3 (HUI-3), the EuroQol (EQ-5D), and the Short Form 6D (SF-6D) and two condition-specific questionnaires: the standardized Asthma Quality of Life Questionnaire (AQLQ(S)) and the Asthma Control Questionnaire (ACQ). The AQLQ(S) scores were converted into the condition-specific preference-based scores: the Asthma Quality of Life Utility Index (AQL-5D).ResultsThe preference-based instruments were generally able to discriminate across control measures, such as ACQ scores and magnitude of asthma medication, but were not able to discriminate for self-reported control and severity levels. These instruments also correlated with most control measures (r = 0.32–0.37). Significant relationships between AQL-5D scores and all control variables were observed.ConclusionsOverall, the AQL-5D discriminated across all levels of asthma control. The HUI-3, the EQ-5D, and the SF-6D differentiated between the highest and lowest levels of control but could not discriminate between the moderate levels.

[1]  J. Brazier,et al.  The use of Rasch analysis as a tool in the construction of a preference based measure: the case of AQLQ , 2007 .

[2]  E. Juniper,et al.  Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? , 2001, Respiratory medicine.

[3]  N. Barnes,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. , 2004, American journal of respiratory and critical care medicine.

[4]  J. Brazier,et al.  Estimating a preference-based single index from the Asthma Quality of Life Questionnaire (AQLQ) , 2007 .

[5]  E. Waclawski.  Health Measurement Scales—A Practical Guide to Their Development and Use , 2010 .

[6]  A. Buist,et al.  Validation of a standardized version of the Asthma Quality of Life Questionnaire. , 1999, Chest.

[7]  L. Lynd,et al.  Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. , 2002, Chest.

[8]  L. Williams,et al.  Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma , 2006, Pediatrics.

[9]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[10]  A. Brennan,et al.  Should patients have a greater role in valuing health states? , 2005, Applied health economics and health policy.

[11]  D A Revicki,et al.  Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. , 1998, Chest.

[12]  M. Johannesson,et al.  Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. , 1997, Journal of health economics.

[13]  P. Dolan,et al.  Time preference, duration and health state valuations. , 1995, Health economics.

[14]  M Terrin,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[15]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[16]  L. Boulet.  Canadian Asthma Consensus Group. Canadian Asthma Consensus Report, 1999 , 1999 .

[17]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[18]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[19]  C. van Weel,et al.  Randomized controlled economic evaluation of asthma self-management in primary health care. , 2002, American journal of respiratory and critical care medicine.

[20]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[21]  D. Dacruz,et al.  Guidelines for management of asthma. , 1990, BMJ.

[22]  G. Guyatt,et al.  Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. , 1999, Journal of clinical epidemiology.

[23]  M. Ferrer,et al.  Health-related quality of life in asthma: A comparison between the St George's respiratory questionnaire and the asthma quality of life questionnaire , 2002, Quality of Life Research.

[24]  D. Cockcroft,et al.  Asthma control versus asthma severity. , 1996, The Journal of allergy and clinical immunology.

[25]  J. Brazier,et al.  A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. , 1999, Health economics.

[26]  C. Thompson,et al.  Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index , 1998, Quality of Life Research.

[27]  Barrett T. Kitch,et al.  Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.

[28]  Standardization of spirometry--1987 update. Statement of the American Thoracic Society. , 1987, The American review of respiratory disease.

[29]  K P Jones,et al.  Guidelines on the management of asthma. , 1993, Thorax.

[30]  K. Blumenschein,et al.  Association between preference-based health-related quality of life and asthma severity. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[32]  M. Weinstein,et al.  Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.

[33]  C. van Weel,et al.  The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. , 2001, American journal of respiratory and critical care medicine.

[34]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.

[35]  Jacek A Kopec,et al.  A comparative review of four preference-weighted measures of health-related quality of life. , 2003, Journal of clinical epidemiology.

[36]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[37]  D. Feeny,et al.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey , 2005, Quality of Life Research.

[38]  J. Brazier,et al.  What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.

[39]  Buist As.  Standardization of spirometry. , 1987 .

[40]  D. Postma,et al.  Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids. , 2003, Respiratory medicine.

[41]  G. Guyatt,et al.  Measuring quality of life in asthma. , 1993, The American review of respiratory disease.

[42]  M. Boyle,et al.  Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.